Author: BusinessWire

Phase 2/3 study expected to enroll 6,750 healthy pediatric participants less than 12 years of age

Study will enroll in the U.S. and Canada
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger R…

Phase 2/3 study expected to enroll 6,750 healthy pediatric participants less than 12 years of age

Study will enroll in the U.S. and Canada
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger R…

Application Based on Objective Response Rate From Phase 2 Trial Evaluating Belzutifan in Patients With Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma

New Filing Further Strengthens Merck’s Expanding and Diverse Oncology Portfolio
KENILWORT…

DUBLIN–(BUSINESS WIRE)–The “Global Biohacking Market (2020-2025) by Product, Application, Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

Ke…

– Italfarmaco Group adds innovative Alzheimer’s disease therapy to its neurology-based product portfolio –
MILAN & BASEL, Switzerland–(BUSINESS WIRE)–Italfarmaco Group (Italfarmaco) and Luye Pharma Switzerland AG (“Luye Switzerland”), a fully owned …

Cold Storage and Distribution Expansions Support Vaccine and Biologics Supply Chain, Keep Pace With Global Industry Trends
PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solu…

Cold Storage and Distribution Expansions Support Vaccine and Biologics Supply Chain, Keep Pace With Global Industry Trends
PHILADELPHIA–(BUSINESS WIRE)–PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solu…

– SUNFISH Part 2 study population includes broad range of ages and disease severities, representing a real-world spectrum of people living with Type 2 or 3 SMA –

– Evrysdi is the first and only at home SMA treatment approved by the FDA, and has prove…

– Plan will create National Opioid Abatement Trust

– Plan will make more than $10 billion in value available for opioid abatement programs across the country

– 100% of Purdue’s assets will be transferred to a new company dedicated at its core to add…

DUBLIN–(BUSINESS WIRE)–The “Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography – G…